Real Possibilities And Great Potential.Experence and very industry knowledable managment. Management’s personal relationships with business owners and executives throughout the industry allows the Company to get access to decision makers and potential targets quickly and effectively.
Salona’s strategy is to acquire companies, paying private company multiples, predominantly through earn-outs heavy in stock. Earn out structures help to keep float tight and allow the company to ensure cash flow and revenue is earned in advance of payment.
SGMD has a deep and full pipeline of potential acquisition targets – all medical device companies with between $5M - $20M in revenues w/ cash flow.
This stock has excellent fundamentals and great price momentum. by Thomson Reuters Stock Reports. It's going to continue to move up and could easly be trading at $2.00 or more by the mid July. It's a good buy.
https://2e0c9480-053d-40d5-b81e-656a8b3c8346.filesusr.com/ugd/3c6412_6b173990300d4e32bb53252bee95fd55.pdf